Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections (Q35355397)

7 August 2017

title

Dose-ranging study of fleroxacin for treatment of uncomplicated Chlamydia trachomatis genital infections (English)

1 reference

7 August 2017

main subject

Chlamydia trachomatis

0 references

author name string

Bowie WR

series ordinal

1

1 reference

7 August 2017

Willetts V

series ordinal

2

1 reference

7 August 2017

Megran DW

series ordinal

3

1 reference

7 August 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

Antimicrobial Agents and Chemotherapy

7 August 2017

published in

1 reference

7 August 2017

volume

33

1 reference

7 August 2017

issue

10

1 reference

7 August 2017

page(s)

1774-1777

1 reference

Tetracycline in nongonococcal urethritis. Comparison of 2 g and 1 g daily for seven days.

7 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

Epidemiology and therapy of Chlamydia trachomatis infections

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

Chlamydia trachomatis infections in the United States. What are they costing us?

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

Adverse effects of the fluoroquinolones.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

In-vitro activity of fleroxacin against Chlamydia trachomatis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

Clinical efficacy and tolerance of fleroxacin in patients with urethritis caused by Chlamydia trachomatis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

Single and multiple dose pharmacokinetics of fleroxacin.

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin and tobramycin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

In vitro activities of T-3262, NY-198, fleroxacin (AM-833; RO 23-6240), and other new quinolone agents against clinically isolated Chlamydia trachomatis strains

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

Adverse reactions in a dose-ranging study with a new long-acting fluoroquinolone, fleroxacin

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

Prediction of efficacy of antimicrobial agents in treatment of infections due to Chlamydia trachomatis

12 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=172753

12 July 2018

Identifiers

DOI

10.1128/AAC.33.10.1774

1 reference

7 August 2017

1 reference

7 August 2017

1 reference